Locations:
Inflammatory protein eotaxin-1 may be a marker of future cognitive decline
Leading investigators outline a new roadmap for clinical trials and observational research
5-year funding award supports cohort expansion and deep phenotyping of AD and related dementias
Free portal helps researchers classify and share data using the IC-CoDE framework
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Experts endorse a push to improve prevention and treatment following repetitive head injury
A population with very high lifetime risk presents care challenges and pathophysiologic insights
Two Cleveland Clinic neurologists review biomarker advances, targeted therapies and unresolved clinical challenges
Alzheimer’s studies delve into preventing and modifying the disease’s trajectory and impact
The disease’s neuropathologic heterogeneity holds clues to refining diagnosis and prognosis
A case study in pairing imaging acumen with subspecialty expertise to yield answers and symptom relief
Advertisement
Advertisement
Search